Abstract
Insulin resistance in skeletal muscle is a key feature in the pathogenesis of type 2 diabetes (T2D) that often manifests early in its development. Pharmaceutical and dietary strategies have targeted insulin resistance to control T2D, and many natural products with excellent pharmacological properties are good candidates for the control or prevention of T2D. Dihydromyricetin (DHM) is a natural flavonol which provides a wide range of health benefits including anti-inflammatory and anti-tumor effects. However, little information is available regarding the effects of DHM on skeletal muscle insulin sensitivity as well as the underlying mechanisms. In the present study, we found that DHM activated insulin signaling and increased glucose uptake in skeletal muscle in vitro and in vivo. The expression of light chain 3, the degradation of sequestosome 1, and the formation of autophagosomes were also upregulated by DHM. DHM-induced insulin sensitivity improvement was significantly abolished in the presence of 3-methyladenine, bafilomycin A1, or Atg5 siRNA in C2C12 myotubes. Furthermore, DHM increased the levels of phosphorylated AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor coactivator-1α (PGC-1α), and Sirt3 in skeletal muscle in vitro and in vivo. Autophagy was inhibited in the presence of Sirt3 siRNA in C2C12 myotubes and in skeletal muscles from Sirt3−/− mice. Additionally, PGC-1α or AMPK siRNA transfection attenuated DHM-induced Sirt3 expression, thereby abrogating DHM-induced autophagy in C2C12 myotubes. In conclusion, DHM improved skeletal muscle insulin sensitivity by partially inducing autophagy via activation of the AMPK-PGC-1α-Sirt3 signaling pathway.
Similar content being viewed by others
Abbreviations
- 3-MA:
-
3-Methyladenine
- Akt:
-
Protein kinase B
- AMPK:
-
AMP-activated protein kinase
- Atg:
-
Autophagy-related gene
- BafA1:
-
Bafilomycin A1
- DHM:
-
Dihydromyricetin
- IRS-1:
-
Insulin receptor substrate-1
- LC3:
-
Light chain 3
- PGC-1α:
-
Peroxisome proliferator-activated receptor coactivator-1α
- siRNA:
-
Small interfering RNA
- T2D:
-
Type 2 diabetes
- Sirt3:
-
Silent mating-type information regulation 2 homolog 3
References
Y.S. Zhang, Z.X. Ning, S.Z. Yang, H. Wu, Yao Xue Xue Bao 38(4), 241–244 (2003)
J.M. Harnly, R.F. Doherty, G.R. Beecher, J.M. Holden, D.B. Haytowitz, S. Bhagwat, S. Gebhardt, J. Agric. Food Chem. 54(26), 9966–9977 (2006)
P. Pu, D.M. Gao, S. Mohamed, J. Chen, J. Zhang, X.Y. Zhou, N.J. Zhou, J. Xie, H. Jiang, Arch. Biochem. Biophys. 518(1), 61–70 (2012)
X. Dai, Y. Ding, Z. Zhang, X. Cai, L. Bao, Y. Li, Biol. Pharm. Bull. 36(5), 788–795 (2013)
Y. Kondo, S. Kondo, Autophagy 2(2), 85–90 (2006)
H.S. Jung, K.W. Chung, K.J. Won, J. Kim, M. Komatsu, K. Tanaka, Y.H. Nguyen, T.M. Kang, K.H. Yoon, J.W. Kim, Y.T. Jeong, M.S. Han, M.K. Lee, K.W. Kim, J. Shin, M.S. Lee, Cell Metab. 8(4), 318–324 (2008)
C. He, M.C. Bassik, V. Moresi, K. Sun, Y. Wei, Z. Zou, Z. An, J. Loh, J. Fisher, Q. Sun, S. Korsmeyer, M. Packer, H.I. May, J.A. Hill, H.W. Virgin, C. Gilpin, G. Xiao, R. Bassel-Duby, P.E. Scherer, B. Levine, Nature 481(7382), 511–515 (2012)
Y. Zhou, X. Liang, H. Chang, F. Shu, Y. Wu, T. Zhang, Y. Fu, Q. Zhang, J.D. Zhu, M. Mi, Cancer Sci. 105(10), 1279–1287 (2014)
E. Jing, B. Emanuelli, M.D. Hirschey, J. Boucher, K.Y. Lee, D. Lombard, E.M. Verdin, C.R. Kahn, Proc Natl Acad Sci USA 108(35), 14608–14613 (2011)
V.K. Yechoor, M.E. Patti, K. Ueki, P.G. Laustsen, R. Saccone, R. Rauniyar, C.R. Kahn, Proc Natl Acad Sci USA 101(47), 16525–16530 (2004)
D. Zou, K. Chen, P. Liu, H. Chang, J. Zhu, M. Mi. Med. Sci. Sports Exerc. (2014)
M.L. Chen, L. Yi, X. Jin, X.Y. Liang, Y. Zhou, T. Zhang, Q. Xie, X. Zhou, H. Chang, Y.J. Fu, J.D. Zhu, Q.Y. Zhang, M.T. Mi, Autophagy 9(12), 2033–2045 (2013)
K. Sawada, K. Kawabata, T. Yamashita, K. Kawasaki, N. Yamamoto, H. Ashida, Lipids Health Dis 11, 36 (2012)
D.J. Powell, S. Turban, A. Gray, E. Hajduch, H.S. Hundal, Biochem. J. 382(Pt 2), 619–629 (2004)
J.J. Senn, J. Biol. Chem. 281(37), 26865–26875 (2006)
C. Schmitz-Peiffer, D.L. Craig, T.J. Biden, J. Biol. Chem. 274(34), 24202–24210 (1999)
B. Levine, G. Kroemer, Cell 132(1), 27–42 (2008)
H.S. Jung, K.W. Chung, K.J. Won, J. Kim, M. Komatsu, K. Tanaka, Y.H. Nguyen, T.M. Kang, K.H. Yoon, J.W. Kim, Y.T. Jeong, M.S. Han, M.K. Lee, K.W. Kim, J. Shin, M.S. Lee, Cell Metab. 8(4), 318–324 (2008)
C. Ebato, T. Uchida, M. Arakawa, M. Komatsu, T. Ueno, K. Komiya, K. Azuma, T. Hirose, K. Tanaka, E. Kominami, R. Kawamori, Y. Fujitani, H. Watada, Cell Metab. 8(4), 325–332 (2008)
H.Y. Liu, J. Han, S.Y. Cao, T. Hong, D. Zhuo, J. Shi, Z. Liu, W. Cao, J. Biol. Chem. 284(45), 31484–31492 (2009)
R. Singh, S. Kaushik, Y. Wang, Y. Xiang, I. Novak, M. Komatsu, K. Tanaka, A.M. Cuervo, M.J. Czaja, Nature 458(7242), 1131–1135 (2009)
T. Yoshizaki, C. Kusunoki, M. Kondo, M. Yasuda, S. Kume, K. Morino, O. Sekine, S. Ugi, T. Uzu, Y. Nishio, A. Kashiwagi, H. Maegawa, Biochem. Biophys. Res. Commun. 417(1), 352–357 (2012)
C. He, M.C. Bassik, V. Moresi, K. Sun, Y. Wei, Z. Zou, Z. An, J. Loh, J. Fisher, Q. Sun, S. Korsmeyer, M. Packer, H.I. May, J.A. Hill, H.W. Virgin, C. Gilpin, G. Xiao, R. Bassel-Duby, P.E. Scherer, B. Levine, Nature 481(7382), 511–515 (2012)
Q. Meng, D. Cai, J. Biol. Chem. 286(37), 32324–32332 (2011)
S. Kume, M.C. Thomas, D. Koya, Diabetes 61(1), 23–29 (2012)
K.H. Kim, Y.T. Jeong, H. Oh, S.H. Kim, J.M. Cho, Y.N. Kim, S.S. Kim, D.H. Kim, K.Y. Hur, H.K. Kim, T. Ko, J. Han, H.L. Kim, J. Kim, S.H. Back, M. Komatsu, H. Chen, D.C. Chan, M. Konishi, N. Itoh, C.S. Choi, M.S. Lee, Nat. Med. 19(1), 83–92 (2013)
S. Imai, F.B. Johnson, R.A. Marciniak, M. McVey, P.U. Park, L. Guarente, Cold Spring Harb. Symp. Quant. Biol. 65, 297–302 (2000)
P. Onyango, I. Celic, J.M. McCaffery, J.D. Boeke, A.P. Feinberg, Proc Natl Acad Sci USA 99(21), 13653–13658 (2002)
B. Schwer, B.J. North, R.A. Frye, M. Ott, E. Verdin, J. Cell Biol. 158(4), 647–657 (2002)
E. Jing, B. Emanuelli, M.D. Hirschey, J. Boucher, K.Y. Lee, D. Lombard, E.M. Verdin, C.R. Kahn, Proc Natl Acad Sci USA 108(35), 14608–14613 (2011)
S.J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams, H. Luo, H. Ke, H. Rehmann, R. Taussig, A.L. Brown, M.K. Kim, M.A. Beaven, A.B. Burgin, V. Manganiello, J.H. Chung, Cell 148(3), 421–433 (2012)
Acknowledgments
This work was supported by the research Grant from National Natural Science Foundation of China (81372975) and the special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Shi, L., Zhang, T., Zhou, Y. et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway. Endocrine 50, 378–389 (2015). https://doi.org/10.1007/s12020-015-0599-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0599-5